PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Mercia Fund Managers
Midlands Engine Investment Fund
EMR & Clinic management, mHealth UK 2022
Nottingham, Nottingham, United Kingdom
$1M to $10M
Register and Claim Ownership